Skip to Main Content

Paper Details

Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients.
medRxiv
2
2023
Author NameAffiliation
Olivier SchwartzInstitut Pasteur, Universite Paris Cite, CNRS UMR9
Olivier SchwartzVaccine Research Institute
  • 1 - 2

Datasets

Release 1.2